Accelerate Diagnostics
Tucson
About Accelerate Diagnostics
Accelerate Diagnostics is a medical device company dedicated to providing solutions to the global challenge of drug-resistant organisms and hospital-acquired infections. It is focused on developing and commercializing innovative instrumentation for the rapid identification and antibiotic susceptibility testing of infectious pathogens. The Company’s revolutionary BACcel platform utilizes a proprietary culture-free process, with both genomic and phenotypic detection technologies, that significantly decreases time to result while achieving high sensitivity and specificity. It was founded in 2004 and is headquartered in Tucson, Arizona.
Company Facts
- Operating status: Active
- Company type: For Profit
- IPO status: Public
- Employees: 101 – 250
- Estimated revenue: $10K – $50K
- Total funding: $264.1M
- Funding stage: IPO
- Last round: Post-IPO Equity (Jan 2024)
- Ticker: nasdaq:AXDX
- Website: acceleratediagnostics.com
- Phone: 520-365-3100
Industries & Categories
Consulting, Health Care, Health Diagnostics, Hospital, Information Technology
Social Profiles
Canonical: https://fsome.com/organization/accelerate-diagnostics-168292 · For the full interactive profile (charts, investors, team, acquisitions, press), please enable JavaScript.